Advertisement
Correspondence

Spinal Delivery of p38: TNF-alpha Inhibitors

  • Edward Tobinick mail

    * etmd@ucla.edu

    Affiliation: Institute for Neurological Research, Los Angeles, California, United States of America

    X
  • Published: November 28, 2006
  • DOI: 10.1371/journal.pmed.0030511

About the Author

Edward Tobinick
Institute for Neurological Research, Los Angeles, California, United States of America

Corresponding Authors

Competing Interests

The author has pending and issued US and international patents, including US patents 6,015,557; 6,982,089; and others, which describe methods of perispinal administration of etanercept. The author also owns stock in Amgen.